INVESTIGATION OF CHEMICAL COMPOSITION AND THERAPEUTIC POTENTIAL OF CAESALPINIA CRISTA POWDER IN DIABETIC MALE PATIENTS

Main Article Content

Khadija Tariq
Anum Nazir
Nizwa Itrat
Mohsen Suliman Alatawi
Deniz Özbilici
Rasha Jame
Awatif M.E. Omran

Keywords

Caesalpinia crista, Diabetes, Antioxidants, Fiber

Abstract

Around 60% of the world's population uses traditional medicines derived from medicinal plants. Diabetes is a metabolic disorder that manifests as either a lack of insulin production by pancreatic beta cells or a failure of the body to properly use the insulin that is generated. Fever nut is an herb that has been used in herbal treatments for many years to manage a range of diseases due to its antioxidants, phytochemical, saponin, and polyphenol content The present study was carried out to investigate the chemical composition and therapeutic potential of Caesalpinia crista powder in diabetic male patients. Physicochemical screening, including proximate profile, minerals, and antioxidant potential, was also investigated for this purpose. The percentages of fat, protein, and fibre in fever nut (Caesalpinia Crista) were found to be 29.3%, 9.5%, and 3.6%, respectively. The DPPH and FRAP levels were found to be 102.3112.06 and 56.3411.27, respectively. Furthermore, the anti-diabetic effects of fever nut powder were evaluated on human male subject. Male Diabetic Patients were divided into three equal groups based on inclusion and exclusion criteria. One group was considered control group G0 given no treatment and the other two groups were considered as treatment groups G1 and G2 received 500mg/day and 1000mg /daycapsules of Caesalpinia crista powder orally every day for the duration of 2 months. After each week, both treatment groups G1 and G2 had minute significant reductions in fasting blood glucose levels and random blood glucose levels. After two months, the overall decline in the G1 group was from 196.50±10.32 to 195.01±9.05 in fasting blood glucose levels and from 197.989±.24 to 197.031±5.21 in random glucose levels. At the end of the study, the fasting blood glucose level in G2 was reduced from 194.11±10.67 to 192.01±8.03, and the random blood glucose level was reduced from 219.96a11.01 to 218.01b15.02. HBA1C levels reduced considerably in treatment groups G1 and G2, with values lowering from 9.57±1.95 to 9.512±.04 in G1 and from 10.85±1.95 to 9.851.70 in± G2. According to the findings of this study, Caesalpinia crista has a significant amount of antioxidants and polyphenols both of which have therapeutic potential and can be used to treat and control diabetes mellitus.

Abstract 337 | Pdf Downloads 107

References

1. Bani KS, Bhardwaj K, Tripathi S. A review on epidemiology, diagnosis, management and treatment of diabetes mellitus.
2. Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-Sunyer X, Hong Y, Eckel RH. Clinical implications of obesity with specific focus on cardiovascular disease. Circulation 2004; 110:2952–67.
3. Singh V, Raghav PK. Review of pharmacological properties of Caesalpinia bonduc L. International Journal of Medicinal and Aromatic Plants 2012;3(2):514-530.
4. Soni, H., & Malik, J. K. (2021). Phyto- pharmacological potential of Zizyphus jujube: A review. Sch Int J Biochem, 4(2), 1-5.
5. Singh, V., & Raghav, P. K. (2012). Review on pharmacological properties of Caesalpinia bonducL. Int J Med Arom Plants, 2(3), 514-530.
6. AOAC, (2005). Official method of Analysis. 18thEdition, Association of officiating Analtical Chemist, Washington DC, Method 935.14 and 992.24
7. Ogungbenle, H.N. (2004). Chemical and Fatty Acidcomposition of Afzelia africana seeds,Advances in analytical chemistry. 4 (2): 30 -34
8. V. L. Singleton and J. A. Rossi, “Colorimetry of total pheno- lics with phosphomolybdic-phosphotungstic acid reagents,” American Journal of Enology and Viticulture, vol. 16, pp. 144– 158, 1965.
9. Gupta N, Sharma I, Agarwal M, Mohammed SM, Chauhan P, Anwer T, Khan G. Antidiabetic activity of seed extracts of Caesalpinia crista Linn. in experimental animals. Afr J Pharm Pharmacol. 2013;7(26):1808-13.
10. Nadaf R. A study of hypoglycemic effect of Caesalpinia bonduc extract on alloxan induced diabetic albino rats. Int. J. Basic Clin. Pharmacol. 2017 Sep;6(2153):2319-003
11. Pandey DD, Jain AP, Kumar A. Caesalpinia bonducella: A pharmacological important plant. The Pharma Innovation Journal 2018 ;7(1-8).

Most read articles by the same author(s)